Jeuveau (prabotulinumtoxinA)

Jeuveau (prabotulinumtoxinA) is a prescription injectable treatment specifically designed for the temporary improvement of moderate to severe frown lines between the eyebrows, also known as glabellar lines. Approved by the FDA in 2019, Jeuveau is known for its focus on aesthetic applications, making it a popular choice among cosmetic patients.

Like other botulinum toxin products, Jeuveau works by blocking nerve signals to the muscles, leading to reduced muscle activity and a smoother appearance in the treated areas. The treatment is typically quick, with injections taking only a few minutes, and results can be seen within a few days. The effects usually last for about three to four months, depending on the individual’s response.

Patients often appreciate Jeuveau for its ability to provide natural-looking results and its specific formulation tailored for cosmetic use. As with any injectable treatment, it’s important to consult with a qualified healthcare provider to discuss your desired outcomes, potential side effects, and the best treatment plan for your unique needs.